+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID05017311

Study to Predict Medication Treatment Outcomes in Adults with Major Depressive Disorder Using Biomarker Data

Led by Nova Scotia Health Authority · Updated on 2026-06-11

400

Participants Needed

10

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a predictive biomarker algorithm designed to guide medication treatment for patients experiencing a major depressive episode within major depressive disorder MDD. This multi-site randomized study builds on data from a previous study and aims to integrate clinical, imaging, EEG, and molecular information to better predict treatment outcomes for participants. The study involves both patients with MDD and healthy controls to collect comprehensive data for analysis. Participants with MDD will be randomly assigned to one of two groups a Personalized Assignment group, where medication selection is guided by the biomarker algorithm, and a Random Assignment group, where medication is assigned without algorithm guidance. All patients receive open-label escitalopram 10-20 mg per day for 12 weeks. Depending on group and response prediction, participants may also receive blinded brexpiprazole 0.5-2 mg per day or placebo for the first 8 weeks, followed by an open-label phase of 4 weeks with medication adjustments based on treatment response. Over the 12-week period, participants attend seven study visits involving clinical assessments, cognitive tests, sample collections blood, urine, stool, neuroimaging MRI and EEG, and speech samples. The main outcome measure is the change in Montgomery Asberg Depression Rating Scale MADRS scores over the first 8 weeks. Researchers will use all collected data to identify features that best predict treatment response. Safety and clinical response will be monitored throughout the study with ongoing evaluations.

CONDITIONS

Brief Title

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

Research Team

J

Jessica B Toombs, MSc

N

Nicole M Stinson, BSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here